www.fdanews.com/articles/210355-spinafx-medicals-triojection-quality-management-system-certified
SpinaFX Medical’s Triojection Quality Management System Certified
December 2, 2022
SpinaFX Medical’s Triojection-associated quality management system has been certified compliant with ISO 13485:2016 and the Medical Device Single Audit Program (MDSAP).
The Triojection system provides minimally-invasive, image-guided needle injection treatments to individual discs in the spine.
The ISO/MDSAP certification is “a critical prerequisite” for gaining regulatory licensing and approval in the U.S., Canada, and Europe for the device, the Canada-based company said.
The audit was conducted by Intertek, which provides testing, inspection and certification services.